NCT02333253View on ClinicalTrials.gov

Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Other Complications Associated With Artificial Fertilization
Interventions
DRUG

cetrotide

0.25 cetrotide S.c was added on when leading follicle reach \>12 mm

Trial Locations (1)

12151

Kasr Alainy medical school, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02333253 - Delayed Start Versus Conventional Antagonist Protocol in Poor Responders Pretreated by Estradiol in Luteal Phase | Biotech Hunter | Biotech Hunter